These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 25919283)
1. Prognostic significance of matrix metalloproteinase-7 in gastric cancer survival: a meta-analysis. Soleyman-Jahi S; Nedjat S; Abdirad A; Hoorshad N; Heidari R; Zendehdel K PLoS One; 2014; 10(4):e0122316. PubMed ID: 25919283 [TBL] [Abstract][Full Text] [Related]
2. Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis. Li S; Wang Z; Huang J; Cheng S; Du H; Che G; Peng Y BMC Cancer; 2016 Nov; 16(1):877. PubMed ID: 27835987 [TBL] [Abstract][Full Text] [Related]
3. Prognostic value of matrix metalloproteinase-9 in gastric cancer: a meta-analysis. Chen J; Chen LJ; Zhou HC; Yang RB; Lu Y; Xia YL; Wu W; Hu LW Hepatogastroenterology; 2014; 61(130):518-24. PubMed ID: 24901174 [TBL] [Abstract][Full Text] [Related]
4. Prognostic and clinicopathological value of Gli-1 expression in gastric cancer: A meta-analysis. Lu L; Wu M; Zhao F; Fu W; Li W; Li X; Liu T Oncotarget; 2016 Oct; 7(42):69087-69096. PubMed ID: 27634907 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of Muc5AC in gastric cancer: A meta-analysis. Zhang CT; He KC; Pan F; Li Y; Wu J World J Gastroenterol; 2015 Sep; 21(36):10453-60. PubMed ID: 26420972 [TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase-9 as a prognostic factor in gastric cancer: a meta-analysis. Zhang QW; Liu L; Chen R; Wei YQ; Li P; Shi HS; Zhao YW Asian Pac J Cancer Prev; 2012; 13(6):2903-8. PubMed ID: 22938481 [TBL] [Abstract][Full Text] [Related]
7. The impact of matrix metalloproteinase 2 on prognosis and clinicopathology of breast cancer patients: a systematic meta-analysis. Chen Y; Wang X; Chen G; Dong C; Zhang D PLoS One; 2015; 10(3):e0121404. PubMed ID: 25816052 [TBL] [Abstract][Full Text] [Related]
8. Integrated analysis of the prognostic role of the lymph node ratio in node-positive gastric cancer: A meta-analysis. Zhu J; Xue Z; Zhang S; Guo X; Zhai L; Shang S; Zhang Y; Lu H Int J Surg; 2018 Sep; 57():76-83. PubMed ID: 30103072 [TBL] [Abstract][Full Text] [Related]
9. The prognostic value of E-cadherin in gastric cancer: a meta-analysis. Xing X; Tang YB; Yuan G; Wang Y; Wang J; Yang Y; Chen M Int J Cancer; 2013 Jun; 132(11):2589-96. PubMed ID: 23169395 [TBL] [Abstract][Full Text] [Related]
10. Heparanase mRNA and Protein Expression Correlates with Clinicopathologic Features of Gastric Cancer Patients: a Meta- analysis. Li HL; Gu J; Wu JJ; Ma CL; Yang YL; Wang HP; Wang J; Wang Y; Chen C; Wu HY Asian Pac J Cancer Prev; 2015; 16(18):8653-8. PubMed ID: 26745132 [TBL] [Abstract][Full Text] [Related]
11. The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature. Lei YY; Huang JY; Zhao QR; Jiang N; Xu HM; Wang ZN; Li HQ; Zhang SB; Sun Z World J Surg Oncol; 2017 Mar; 15(1):68. PubMed ID: 28327158 [TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase-9 is associated with disease-free survival and overall survival in patients with gastric cancer. Chu D; Zhang Z; Li Y; Zheng J; Dong G; Wang W; Ji G Int J Cancer; 2011 Aug; 129(4):887-95. PubMed ID: 20957628 [TBL] [Abstract][Full Text] [Related]
13. The prognostic role of matrix metalloproteinase 2 in gastric cancer: a systematic review with meta-analysis. Shen W; Xi H; Wei B; Chen L J Cancer Res Clin Oncol; 2014 Jun; 140(6):1003-9. PubMed ID: 24610446 [TBL] [Abstract][Full Text] [Related]
14. Expression of chemokine receptor CCR7 is a negative prognostic factor for patients with gastric cancer: a meta-analysis. Du P; Liu Y; Ren H; Zhao J; Zhang X; Patel R; Hu C; Gan J; Huang G Gastric Cancer; 2017 Mar; 20(2):235-245. PubMed ID: 26984468 [TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic and prognostic significance of human epidermal growth factor receptor in patients with gastric cancer: An updated meta-analysis. Zhang Z; Tang H; Lin J; Hu Y; Luo G; Luo Z; Cheng C; Wang P Oncotarget; 2017 Mar; 8(10):17202-17215. PubMed ID: 28199988 [TBL] [Abstract][Full Text] [Related]
16. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis. Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926 [TBL] [Abstract][Full Text] [Related]
17. Integrin αvβ6 and matrix metalloproteinase 9 correlate with survival in gastric cancer. Lian PL; Liu Z; Yang GY; Zhao R; Zhang ZY; Chen YG; Zhuang ZN; Xu KS World J Gastroenterol; 2016 Apr; 22(14):3852-9. PubMed ID: 27076771 [TBL] [Abstract][Full Text] [Related]
18. Bcl-2 expression and patient survival in gastric cancer: a systematic review of the literature with meta-analysis. Cheng H; Wang X; Li T; Chen L Med Oncol; 2015 Jan; 32(1):389. PubMed ID: 25428392 [TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic significance and prognostic value of Ki-67 expression in patients with gastric cancer: a meta-analysis. Luo G; Hu Y; Zhang Z; Wang P; Luo Z; Lin J; Cheng C; Yang Y Oncotarget; 2017 Jul; 8(30):50273-50283. PubMed ID: 28488584 [TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of MMP-7 expression in colorectal cancer: a meta-analysis. Sun DW; Zhang YY; Qi Y; Zhou XT; Lv GY Cancer Epidemiol; 2015 Apr; 39(2):135-42. PubMed ID: 25677090 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]